Abstract
Schizophrenia is a common complex disorder characterized by psychosis, cognitive dysfunction and negative symptoms, whose etiology involves interactions between both genetic and environmental vulnerability factors. Recently, ongoing research attempting to elucidate the nature of these vulnerability factors has been generating exciting findings. The advances in understanding of environmental risk factors for mental illnesses and in genetic research into mental illnesses will be reviewed. Limitations of the findings and implications of these advances for genetic counseling practice will also be discussed.
Similar content being viewed by others
References
AbdelMalik, P., Husted, J., Chow, E. W., & Bassett, A. S. (2003). Childhood head injury and expression of schizophrenia in multiply affected families. Arch Gen Psychol, 60(3), 231–236.
Aleman, A., Kahn, R. S., & Selten, J.-P. (2003). Sex differences in the risk of schizophrenia. Arch Gen Psychol, 60, 565–571.
Armenteros, J. L., Fennelly, B. W., Hallin, A., Adams, P. B., Pomerantz, P., Michell, M., Sanchez, L. E., & Campbell, M. (1995). Schizophrenia in hospitalized adolescents: Clinical diagnosis, DSM-IIIR, DSM-IV, and ICD-10. Psychopharmacol Bull, 31(2), 383–387.
Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004). Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry, 184, 110–117.
American Psychiatric Association (2004). Practice guideline for the treatment of patients with schizophrenia, 2nd ed. Washington, DC: American Psychiatric Association.
Austin, J. C. (2004). Knowledge and perceptions regarding genetics and mental illness: A survey on individuals affected by mental illness and their families. Am J Med Genet, 130B(1), 20.
Austin, J. C., & Honer, W. G. (2005). The potential impact of genetic counseling for mental illness. Clin Genet, 67(2), 134–142.
Bassett, A. S., & Chow, E. W. C. (1999). 22q11 deletion syndrome: A genetic subtype of schizophrenia. Biol Psychiatry, 46, 882–891.
Berrettini, W. (2003). Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet, 123C, 59– 64.
Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton,~N., Owen, M. J., & O'Donovan, M. C. (2003). A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet, 73(1), 152–161.
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004). Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychol, 61, 774–780.
Brzustowicz, L. M., Simone, J., Mohseni, P., Hayter, J. E., Hodgkinson, K. A., Chow, E. W. C., & Bassett, A. S. (2004). Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of Chromosome 1q22. Am J Hum Genet, 74, 1057–1063.
Buka, S. L., Tsuang, M. T., Torrey, F., Klebanoff, M. A., Bernstein,~D., & Yolken, R. H. (2001). Maternal infections and subsequent psychosis among offspring. Arch Gen Psychol, 58, 1032–1037.
Bustillo, J., Lauriello, J., Horan, W., & Keith, S. (2001). The psychosocial treatment of schizophrenia: And update. Am J Psychiatry, 158(2), 163–175.
Byrne, M., Agerbo, E., Ewald, H., Eaton, W. W., & Mortensen, P. B. (2003). Parental age and risk of schizophrenia. Arch Gen Psychol, 60, 673–678.
Cannon M, Jones, P. B., & Murray, R. M. (2002). Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry, 159(7), 1080–1092.
Cardno, A. G., Marshall, E. J., Coid, B., Macdonald, A. M., Ribchester, T. R., Davies, N. J., Venturi, P., Jones, L. A., Lewis, S. W., Sham, P. C., Gottesman, I. I., Farmer, A. E., McGuffin, P., Reveley, A. M., & Murray, R. M. (1999). Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychol, 56(2), 162–168.
Chakravarti, A., & Little, P. (2003). Nature, nurture and human disease. Nature, 421, 412–414.
Chambers, R. A., Krystal, J. H., & Self, D. W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry, 50, 71–83.
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., & Weinberger, D. R. (2004). Functional analysis of genetic variation in Catechol-O-Methyl transferase (COMT): Effects of mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet, 75, 807–821.
Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., Deshpande, S. N., Ferrell, R. E., Middleton, F. A., Devlin, B., Levitt, P., Lewis, D. A., & Nimgaonkar, V. L. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet, 11(12), 1373–1380.
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., Puech, A., Tahri, N., Cohen-Akenine, A., Delabrosse, S., Lissarrague, S., Picard, F. P., Maurice, K., Essioux, L., Millasseau, P., and Grel, P. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci, 99(21), 13675–13680.
Cloninger, C. R. (2002). The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci, 99(21), 13365– 13367.
Collier, D. A., & Li, T. (2003). The genetics of schizophrenia: Glutamate not dopamine? Eur J Pharmacol, 480, 177–184.
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. F. H., Mazzanti, C. M., Straub, R. E., Goldman, D.,& Weinberger, D. R. (2001). Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci, 98(12), 6917–6922.
Gamm, J. L., Nussbaum, R. L., & Biesecker, B. B. (2004). Genetics and Alcoholism among at-risk relatives I: Perceptions of cause, risk, and control. Am J Med Genet, 128A, 144–150.
Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., & Tonegawa, S. (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci, 100(15), 8993–8998.
Gispen-de Wied, C. (2000). Stress in schizophrenia: AN integrative view. Eur J Pharmacol, 405, 375–384.
Gottesman, I. (1991). Schizophrenia genesis: The origins of madness. New York: W-H Freeman.
Gottesman, I. I., & Bertelsen, A. (1989). Confirming unexpressed genotypes for schizophrenia. Arch Gen Psychol, 46, 867–872.
Harrison, P. J., & Owen, M. J. (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. The Lancet, 361, 417–419.
Holzinger, A., Kilian, R., Lindenbach, I., Petscheleit, & Angermeyer, M. C. (2003). Patients' and their relatives' causal explanations of schizoprenia. Soc Psychiatry Psychiatr Epidemiol, 38, 155–162.
Hunt, K., Davidson, C., Emslie, C., & Ford, G. (2000). Are perceptions of a family hisrtory of heart disease related to health-related attitudes and behavior? Health Educ Res, 15, 131–143.
Hutchinson, G., & Haasen, C. (2004). Migration and schizophrenia. The challenges for European psychiatry and implications for the future. Soc Psychiatry Psychiatr Epidemiol, 39, 350–357.
Jablensky, A., Sartorius, N., Emberg, G., Anker, M., Korten, A., Cooper, J. E. (1992). Schizophrenia: Manifestations, incidence, and course in different cultures—A World Heath Organisation ten-country study. Psychol Med Monograph Suppl, 20, 1–97.
Johnson, D. (1990). The families experience of living with mental illness. In H. P. Lefley & D. J. Johnson (Eds.), Families as allies in the treatment of the mentally ill (pp.~31–64). Washington, DC, American Psychiatric Association.
Karlsson, H. (2003). Viruses and schizophrenia, connection or coincidence. NeuroReports, 14(4), 535–542.
Kringlen, E., Cramer, G. (1989). Offspring of monozygotic twins discordant for schizophrenia. Arch Gen Psych, 46, 873– 877.
Landsverk, S. S., & Kane, C. F. (1998). Antonovsky's sense of coherence: A theoretical basis of psychoeducation in schizophrenia. Issues Ment Health Nurs, 19, 419–431.
Limosin, F., Rouillon, F., Payan, C., Cohen, J. M., & Strub, N. (2003). Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand, 107(5), 331–335.
Link, B. G., Mirotznik, J., & Cullen, F. T. (1991). The effectiveness of stigma coping orientations: Can negative consequences of mental illness labeling be avoided? J Health Soc Behav, 32, 302–320.
Link, B. G., Struening, E. L., Neese-Todd, S., Asmussen, S., & Phelan, J. C. (2001). The consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv, 52(12), 1621–1626.
Malaspina, D., Harlap, S., Fennig, S., Heiman, D., Nahon, D., Feldman, D., Feldman, D., & Susser, E. S. (2001). Advancing paternal age and the risk of schizophrenia. Arch Gen Psychol, 58, 361–367.
Marcelis, M., Navarro-Mateu, F., Murray, R., Selten, J. P., & Van Os, J. (1998). Urbanization and psychosis: A study of 1942–1978 birth cohorts in the Netherlands. Psychol Med, 28, 871–879.
McFarlane, W. R. (2002). Multifamily groups in the treatment of severe psychiatric disorders. New York: Guildford.
McGorry, P. D. (1995). Psychoeducation in first-episode psychosis: A therapeutic process. Psychiatry, 58, 313–328.
McGorry, P. D., & Yung, A. R. (2003). Early intervention in psychosis: An overdue reform. Aust NZ J Psychiatry, 37(4), 393–398.
Mechanic, D., McAlpine, D., Rosenfield, S., & Davis, D. (1994). Effects of illness attribution and depression on the quality of life among persons with serious mental illness. Soc Sci Med, 39(2), 155–164.
Merikangas, K. R., & Risch, N. (2003). Will the genomics revolution revolutionise psyhiatry? Am J Psychiatry, 160, 625–635.
Merinder, L. B. (2000). Patient education in schizophrenia: A review. Acta Psychiatr Scand, 102, 98–106.
Mikami, T., Naruse, N., Fukura, Y., Ohkubo, H., Ohkubo, T., Matsuura, M., Moriya, H., Nishikawa, T., & Kojima, T. (2003). Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiatry Clin Neurosci, 57(4), 433–440.
Moghaddam, B. (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881–884.
Mortensen, P. B., Pedersen, C. B., Westergaard, T., Wohlfahrt, J., Ewald, H., Mors, O., Andersen, P. K., & Melbye, M. (1999). Effects of family history and place and season on birth on the risk of schizophrenia. N Engl J Med, 340, 603–608.
Muesser, K. T., & McGurk, S. R. (2004). Schizophrenia. Lancet, 363, 2063–2072.
Murphy, K. C. (2002). Schizophrenia and velo-cardio-facial syndrome. The Lancet, 359, 426–430.
Myles-Worsley, M., Coon, H., Tiobech, J., Collier, J., Dale, P., Wender, P., Reimerr, F., Polloi, A., & Byerley, W. (1999). Genetic epidemiological study of schizophrenia in Palau, Micronesia: Prevalence and Familiality. Am J Med Genet, 88, 4–10.
Nechmad, A., Fennig, S., Ternochiano, P., Treves, I., Fennig-Naisberg, S., & Levkovich, Y. (2000). Siblings of schizophrenic patients—A review. Isr J Psychiatry Relat Sci, 37(1), 3–11.
Ni, Y. G., Gold, S. J., Iredale, P. A., Terwilliger, R. Z., Duman, R. S., & Nestler, E. J. (1999). Region specific regulation of RGS4 (Regulator of G-protein-signalling protein type 4) in brain by stress and glucocorticoids: In vivi and in vitro studies. J Neurosci, 19(10), 3674–3680.
Nielsen, A. S., Mortensen, P. B., O'Callaghan, E., Mors, O., & Ewald, H. (2002). Is head injury a risk factor for schizophrenia? Schizophr Res, 55, 93–98.
Owen, M. J., O'Donovan, M. C., & Gottesman, I. I. (Eds.) (2002). Schizophrenia. Psychiatric genetics and genomics (pp.~247–266). Oxford: Oxford University Press.
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004a). The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry, 9(1), 14–27.
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004b). Dysbindin-1 and schizophrenia: From genetics to neuropathy. J Clin Invest, 113, 1255–1257.
Pedersen, C. B., & Mortensen, P. B. (2001). Evidence of a dose-response relationship between urbancity during upbringing and schizophrenia risk. Arch Gen Psychol, 58, 1039–1046.
Phelan, J. C. (2002). Genetic bases of mental illness—a cure for stigma? Trends Neurosci, 25(8), 430–431.
Phelan, J. C., Bromet, E. J., & Link, B. G. (1998). Psychiatric illness and family stigma. Schizophr Bull, 24(1), 115–126.
Phillips, M. R., Pearson, V., Li, F., Xu, M., & Yang, L. (2002). Stigma and expressed emotion: A study of people with schizophrenia and their family members in China. Br J Psychiatry, 181, 488–493.
Plomin, R., Owen, M. J., & McGuffin, P. (1994). The genetic basis of complex human behaviours. Science, 264, 1733–1739.
Resnick, S. G., Bond, G. R., & Muesser, K. T. (2003). Trauma and post-traumatic stress disorder in people with schizophrenia. J Abnorm Psychol, 112(3), 415–423.
Risch, N. (1990). Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet, 46(2), 222–228.
Rose, S. (1995). The rise of neurogenetic determinism. Nature, 373, 380–382.
Sartorius, N. (1997). Fighting schizophrenia and its stigma. A new World Psychiatric Association educational program. Br J Psychiatry, 170, 297.
Seedat, S., Stein, M. B., Oosthuizen, P. P., Emsley, R., & Stein, D. J. (2003). Linking posttraumatic stress disorder and psychosis: A look at epidemiology, phenomenology, and treatment. J Nerv Ment Dis, 191(10), 675–681.
Senior, V., Marteau, T. M., & Peters, T. J. (1999). Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Soc Sci Med, 48, 1857–1860.
Shifman, S., Bronstein, M., Sternfeld, M., Pisante, A., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., Schiffer, R., Kotler, M., Strous, R. D., Swartz-Vanetic, M., Knobler, H. Y., Shinar, E., Yakir, B., Zak, N. B., & Darvasi, A. (2004). COMT: A common susceptibility gene in Bipolar disorder and schizophrenia. Am J Med Genet, 128B, 61–64.
Shifman, S., Bronstein, M., Sternfeld, M., Pisante-Shalom, A., Lev-Lehman, Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., Schiffer, R., Kotler, M., Strous, R. D., Swartz-Vanetic, M., Knobler, H. Y., Shinar, E., Beckmann, J. S., Yakir, B., Risch, N., Zak, N. B., & Darvasi, A. (2002). A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet, 71, 1296–1302.
Skirton, H., & Eiser, C. (2003). Discovering and addressing the client's lay construct of genetic disease: An important aspect of genetic healthcare? Res Theory Nurs Pract., 17(4), 339– 352.
Smit, F., Bolier, L., & Cuijpers, P. (2004). Cannabis use and the risk of later schizophrenia: A review. Addiction, 99(4), 425–430.
Stalberg, G., Ekerwald, H., & Hultman, C. M. (2004). At issue: Siblings of patients with schizophrenia: Sibling bond, coping patterns, and fear of possible schizophrenia heredity. Schizophr Bull, 30(2), 445–458.
Stefansson, H., Sigurdson, E., Steinhorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnardsdottir, S., Ivarsson, O., Chou, T. T., Hjaltson, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Ingvarsson, B., & Ingason, A. (2002). Neuregulin-1 and susceptibility to schizophrenia. Am J Hum Genet, 71, 877–892.
Stefansson, H., Steinthordottir, V., Thorgeirsson, T. E., Gulcher, J. R., & Stefansson, K. (2004). Neuregulin 1 and schizophrenia. Ann Med, 36, 62–71.
Straub, R. E., Jiang, Y., Maclean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., Cesare, A. J., Gibberman, A., Wang, X., O'Neill, F. A., Walsh, D., & Kendler, K. S. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet, 71(2), 337–348.
Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., Blake, D. J., & Arnold, S. E. (2004). Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest, 113, 1353–1363.
Taylor, S. E. (1983). Adjustment to threatening events: A theory of cognitive adaptation. Am Psychol, 11, 1161–1173.
Tochigi, M., Okazaki, Y., Kato, N., & Sasaki, T. (2004). What causes seasonality of birth in schizophrenia? Neurosci Res, 48, 1–11.
Torrey, E. F., Miller, J., Rawlings, R., & Yolken, R. H. (1997). Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizophr Res, 28, 1–38.
Uhl, G. R., & Grow, R. W. (2004). The burden of complex genetics in brain disorders. Arch Gen Psychol, 61, 223– 229.
Winefield, H. (1993). Determinants of psychological distress in relatives of people with chronic schizophrenia. Schizophr Bull, 19, 619–625.
Wolpert, C. M., Melvin, E. C., & Speer, M. C. (1999). Complex genetic disorders: Evaluating when genetic research findings are applicable for genetic counseling practice. J Genet Counsel, 8(2), 73–84.
Yolken, R. (2004). Viruses and schizophrenia: A focus on herpes simplex virus. Herpes, 11, 83A–88A.
Zammit, S., Allbeck, P., Dalman, C., Lundberg, I., Hemmingson, T., & Owen, M. J. (2003). Paternal age and risk for schizophrenia. Br J Psychiatry, 183, 405–408.
Zubin, J., Magaziner, J., & Steinhauer, S. R. (1983). The metamorphosis od schizophrenia: From chronicity to vulnerability. Psychol Med, 13, 551–571.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Austin, J. Schizophrenia: An Update and Review. J Genet Counsel 14, 329–340 (2005). https://doi.org/10.1007/s10897-005-1622-4
Issue Date:
DOI: https://doi.org/10.1007/s10897-005-1622-4